Comgest Growth Europe EUR AccRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31-03-2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 10,7 | 34,7 | -20,6 | 23,2 | 11,7 | |
+/-Cat | 2,2 | 10,2 | -0,1 | 7,0 | 3,2 | |
+/-Idx | 4,8 | 6,7 | -2,9 | 7,0 | 1,4 | |
Categorie: Aandelen Europa Large-Cap Groei | ||||||
Categorie Benchmark: MSCI Europe Growth NR EUR |
Kerngegevens | ||
Koers 23-04-2024 | EUR 46,17 | |
Rendement 1 Dag | 1,45% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Groei | |
Vestigingsland | Ierland | |
ISIN | IE0004766675 | |
Grootte Fonds (Mil) 23-04-2024 | EUR 6381,27 | |
Grootte Fondsklasse (Mil) 23-04-2024 | EUR 1229,40 | |
Aankoopkosten (Max) | 4,00% | |
Lopende Kosten Factor 21-03-2024 | 1,56% |
Morningstar Research |
Analyst Report | 20-09-2023 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Klik hier voor het analistenrapport |
Pijlers Morningstar | |
---|---|
Team | 25 |
Fondshuis | 24 |
Proces | 25 |
Rendement | |
Kosten |
Beleggingsdoelstelling: Comgest Growth Europe EUR Acc |
The investment objective of the Comgest Growth Europe fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies based or operating in Europe. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Franz Weis 01-11-2009 | ||
Pierre Lamelin 28-02-2022 | ||
Click here to see others | ||
Oprichtingsdatum 15-05-2000 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI Europe NR EUR | MSCI Europe Growth NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Comgest Growth Europe EUR Acc | 31-12-2023 |
|
|
Top 5 posities | Sector | % |
Novo Nordisk A/S Class B | Gezondheidszorg | 7,76 |
ASML Holding NV | Technologie | 7,71 |
Essilorluxottica | Gezondheidszorg | 4,66 |
Accenture PLC Class A | Technologie | 4,62 |
Linde PLC | Grondstoffen | 4,10 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
Comgest Growth Europe EUR Acc |